CIP
NAGE

Cornerstone Investment Partners’s Niagen Bioscience NAGE Stock Holding History

Cornerstone Investment Partners’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,875
Closed -$158K – 333
2025
Q4 		$158K Buy
+24,875
New +$173K 0.01% 205
2025
Q3 		– Sell
-24,492
Closed -$353K – 258
2025
Q2 		$353K Buy
24,492
+10
+0% +$99 0.02% 86
2025
Q1 		$169K Sell
24,482
-2,122
-8% -$13.3K 0.01% 148
2024
Q4 		$141K Buy
+26,604
New +$146K 0.01% 236

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cornerstone Investment Partners's NAGE Position: Q1 2026 in Review

Cornerstone Investment Partners sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 24,875 shares — an estimated $158K sold.

Cornerstone Investment Partners first reported a position in NAGE in Q4 2024 and held it in 4 quarters. The position peaked at $353K in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Cornerstone Investment Partners reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Cornerstone Investment Partners sold 24,875 Niagen Bioscience shares in Q1 2026, an estimated $158K.
  • Cornerstone Investment Partners first reported a position in Niagen Bioscience in Q4 2024 and held it in 4 quarters.
  • Cornerstone Investment Partners's Niagen Bioscience position peaked at $353K in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Cornerstone Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.